French Health Minister Olivier Veran said that French health authorities should announce today that the first group of people under 55 who take AstraZeneca will receive a second dose of Messenger-RNA vaccination.
Veran said this is a preventive measure until further data on the AstraZeneca vaccine is collected, and France continues to encourage the use of the vaccine. Reuters.
France has approved two mRNA vaccines: one from Pfizer/BioNTech and the other from Moderna.
Messenger-RNA vaccine stimulates the body to produce a protein that mimics the part of the virus that enters the cell to trigger an immune response, while traditional vaccines such as AstraZeneca use inactive viruses.